For media or press inquiries, contact:
Ichor Life Sciences, a preclinical contract research organization, plans to invest $1.5 million in MitoChem Therapeutics of Charleston.
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative diseases.
MitoChem Therapeutics and Ichor Life Sciences will work together to advance the development of a small molecule pharmaceutical eyedrop, targeting the mitochondria to treat age-related eye disease, according to a news release.
Read full article, HERE.
For media or press inquiries, contact:
[email protected] or call us at +1 843.767.9300
